{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04296006",
            "orgStudyIdInfo": {
                "id": "BED(In)(41)"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA045023",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA045023"
                }
            ],
            "organization": {
                "fullName": "University of Kentucky",
                "class": "OTHER"
            },
            "briefTitle": "Neurobehavioral Mechanisms of Cocaine Choice",
            "officialTitle": "Neurobehavioral Mechanisms of Cocaine Choice",
            "therapeuticArea": [
                "Other"
            ],
            "study": "neurobehavioral-mechanisms-of-cocaine-choice"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-01-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-02-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-03-02",
            "studyFirstSubmitQcDate": "2020-03-02",
            "studyFirstPostDateStruct": {
                "date": "2020-03-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Joshua A. Lile, Ph.D.",
                "investigatorTitle": "Professor of Behavioral Science",
                "investigatorAffiliation": "University of Kentucky"
            },
            "leadSponsor": {
                "name": "Joshua A. Lile, Ph.D.",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this protocol is to use a drug-vs-money choice task, reinforcement learning modeling and fMRI to determine the neurobehavioral and neurobiological decision-making \"profile\" associated with the decision to take cocaine and the reduced cocaine choice that occurs during behavioral and pharmacological interventions."
        },
        "conditionsModule": {
            "conditions": [
                "Cocaine Use Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "A placebo-controlled, randomized, within-subjects design will be used to assess drug-vs-money choice in cocaine use disordered subjects as a function of alternative reinforcer value and d-amphetamine SR treatment.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "d-Amphetamine doses will be administered under double-blind conditions.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active Treatment",
                    "type": "EXPERIMENTAL",
                    "description": "Cocaine choice during d-amphetamine maintenance",
                    "interventionNames": [
                        "Drug: Sustained Release d-amphetamine",
                        "Behavioral: Money"
                    ]
                },
                {
                    "label": "Placebo Treatment",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Cocaine choice during placebo maintenance",
                    "interventionNames": [
                        "Drug: Sustained Release d-amphetamine",
                        "Behavioral: Money"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Sustained Release d-amphetamine",
                    "description": "Twice daily administration of active or placebo d-amphetamine",
                    "armGroupLabels": [
                        "Active Treatment",
                        "Placebo Treatment"
                    ],
                    "otherNames": [
                        "Dexedrine Spansule SR"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Money",
                    "description": "Three money values offered as alternatives to cocaine",
                    "armGroupLabels": [
                        "Active Treatment",
                        "Placebo Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative",
                    "description": "The reinforcing effects of cocaine are determined using a reinforcement learning choice task. Subjects complete trials in which they could possibly receive the available cocaine dose or money. Reinforcing effects are measured for a fixed cocaine dose during both d-amphetamine and placebo maintenance and when three amounts of money are available as alternatives to cocaine.",
                    "timeFrame": "Choices occur across a 40 minute session"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Recent cocaine use, otherwise healthy\n\nExclusion Criteria:\n\n* Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Joshua Lile, PhD",
                    "affiliation": "University of Kentucky",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Laboratory of Human Behavioral Pharmacology",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40536-0086",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Frances Wagner, RN",
                            "role": "CONTACT",
                            "phone": "859-257-5388",
                            "email": "fpwagn2@uky.edu"
                        },
                        {
                            "name": "Joshua A. Lile, Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000661",
                    "term": "Amphetamine"
                },
                {
                    "id": "D000003913",
                    "term": "Dextroamphetamine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000697",
                    "term": "Central Nervous System Stimulants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000015259",
                    "term": "Dopamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018759",
                    "term": "Adrenergic Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000018765",
                    "term": "Dopamine Uptake Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6271",
                    "name": "Cocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M3997",
                    "name": "Amphetamine",
                    "asFound": "Foot Ulcers",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7108",
                    "name": "Dextroamphetamine",
                    "asFound": "Cognitive Stimulation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M7473",
                    "name": "Dopamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17962",
                    "name": "Dopamine Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20832",
                    "name": "Dopamine Uptake Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}